Conference
Prognostic and predictive significance of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.
Authors
Gelmon KA; Chapman J-AW; Liu S; Burnell MJ; Levine MN; Pritchard KI; Whelan TJ; Rugo HS; Albain KS; Perez EA
Volume
32
Pagination
pp. 11019-11019
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2014
DOI
10.1200/jco.2014.32.15_suppl.11019
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X